8852
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,409,160) Views
Editor in Chief Professor Garry Walsh
1178-203X
ReviewPrevention and management of accidental foreign body ingestion and aspiration in orthodontic practice
Umesan UK, Chua KL, Balakrishnan P
Therapeutics and Clinical Risk Management 2012, 8:245-252
23 May 2012
Letter
Pain management with morphine: variation in analgesic response secondary to genetic polymorphisms
Kapoor S
Therapeutics and Clinical Risk Management 2012, 8:243-244
21 May 2012
Review
Pharmacological management of binge eating disorder: current and emerging treatment options
McElroy SL, Guerdjikova AI, Mori N, O’Melia AM
Therapeutics and Clinical Risk Management 2012, 8:219-241
08 May 2012
Short Report
The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation Strategy
Gudin JA
Therapeutics and Clinical Risk Management 2012, 8:209-217
01 May 2012
Review
Role of gabapentin enacarbil XR in restless legs syndrome
Sivam S, Yee BJ
Therapeutics and Clinical Risk Management 2012, 8:201-208
01 May 2012
Case report
Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures
Iwamoto J , Sato Y, Uzawa M, Matsumoto H
Therapeutics and Clinical Risk Management 2012, 8:195-199
10 April 2012
Review
Maximizing neuroprotection: where do we stand?
Kuffler DP
Therapeutics and Clinical Risk Management 2012, 8:185-194
10 April 2012
Case report
Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease
Michel S, Bigdeli AK, Beiras-Fernandez A, Schmitz C, Wolf M, Sodian R, Kaczmarek I
Therapeutics and Clinical Risk Management 2012, 8:181-183
11 April 2012
Review
Optimal management of giant cell arteritis and polymyalgia rheumatica
Charlton R
Therapeutics and Clinical Risk Management 2012, 8:173-179
05 April 2012
Letter
Measurement complexity of adherence to medication
Galato D, Schuelter-Trevisol F, Piovezan AP
Therapeutics and Clinical Risk Management 2012, 8:169-171
02 April 2012
Review
Human normal immunoglobulin in the treatment of primary immunodeficiency diseases
Wood P
Therapeutics and Clinical Risk Management 2012, 8:157-167
02 April 2012
Review
Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections
Goodman JJ, Martin SI
Therapeutics and Clinical Risk Management 2012, 8:149-156
26 March 2012
Review
Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery
Werth S, Halbritter K, Beyer-Westendorf J
Therapeutics and Clinical Risk Management 2012, 8:139-147
23 March 2012
Review
Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)
Hooper CY, Smith WJ
Therapeutics and Clinical Risk Management 2012, 8:131-137
16 March 2012
Original Research
Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis
Cooper CL, Druyts E, Thorlund K, Nachega JB, El Khoury AC, O'Regan C, Mills EJ
Therapeutics and Clinical Risk Management 2012, 8:105-130
09 March 2012
Review
Ruxolitinib for the treatment of myelofibrosis: its clinical potential
Ostojic A, Vrhovac R, Verstovsek S
Therapeutics and Clinical Risk Management 2012, 8:95-103
01 March 2012
Original Research
NIHSS and acute complications after anterior and posterior circulation strokes
Video available for this paperBoone M, Chillon JM, Garcia PY, Canaple S, Lamy C, Godefroy O, Bugnicourt JM
Therapeutics and Clinical Risk Management 2012, 8:87-93
27 February 2012
Review
Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus
Hagihara M, Umemura T, Mori T, Mikamo H
Therapeutics and Clinical Risk Management 2012, 8:79-86
17 February 2012
Original Research
Noninvasive radioelectric asymmetric conveyor brain stimulation treatment improves balance in individuals over 65 suffering from neurological diseases: pilot study
Fontani V, Rinaldi S, Castagna A, Margotti ML
Therapeutics and Clinical Risk Management 2012, 8:73-78
17 February 2012
Review
Coronary artery disease in Africa and the Middle East
Almahmeed W, Arnaout MS, Chettaoui R, Ibrahim M, Kurdi MI, Taher MA, Mancia G
Therapeutics and Clinical Risk Management 2012, 8:65-72
16 February 2012
Original Research
Metabolic syndrome in a sample of the 6- to 16-year-old overweight or obese pediatric population: a comparison of two definitions
Saffari F, Jalilolghadr S, Esmailzadehha N, Azinfar P
Therapeutics and Clinical Risk Management 2012, 8:55-63
02 February 2012
Review
Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility
Witkiewitz K, Saville KA, Hamreus K
Therapeutics and Clinical Risk Management 2012, 8:45-53
01 February 2012
Review
New treatment options for lupus – a focus on belimumab
Chiche L, Jourde N, Thomas G, Bardin N, Bornet C, Darque A, Mancini J
Therapeutics and Clinical Risk Management 2012, 8:33-43
26 January 2012
Original Research
Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions
Zeller RS, Davidson J, Lee HM, Cavanaugh PF
Therapeutics and Clinical Risk Management 2012, 8:25-32
25 January 2012
Original Research
Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions
Zeller RS, Lee HM, Cavanaugh PF, Davidson J
Therapeutics and Clinical Risk Management 2012, 8:15-23
25 January 2012
Review
Clinical utility of adjunctive retigabine in partial onset seizures in adults
Rejdak K, Luszczki JJ, Błaszczyk B, Chwedorowicz R, Czuczwar SJ
Therapeutics and Clinical Risk Management 2012, 8:7-14
20 January 2012
Review
Aripiprazole in the acute and maintenance phase of bipolar I disorder
Zupancic M, Gonzalez ML
Therapeutics and Clinical Risk Management 2012, 8:1-6
12 January 2012
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
